Option chain shows key data for Private Bancorp's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Private Bancorp.

Private Bancorp (OTC:PBAM) Stock, Option Chain

Private Bancorp

Private Bancorp of America Inc operates through its bank holding which is a commercial bank chartered by the State of California. The bank provides deposit and loan services and also specializes in making loans on commercial real estate, as well as small to mid-sized business loans. Its offerings also include personal and business banking. The company operates in La Jolla, San Diego, Coronado, Newport Beach, Beverly Hills, El Segundo, San Marcos, Temecula, and Redlands.

Earnings

News

Price Target

Small Cap

Markets

Analyst Ratings

Trading Ideas

PBAM

Shares of Private Bancorp of America, Inc. (OTC: PBAM) have gained 2.4% over the past four weeks to close the last trading session at $43, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication.

Wall Street Analysts Think Private Bancorp of America Could Surge 36.44%: Read This Before Placing a Bet

When it comes to short-term investing or trading, they say &#34;the trend is your friend.&#34; And there&#39;s no denying that this is the most profitable strategy. But making sure of the sustainability of a trend to profit from it is easier said than done.

Private Bancorp of America Is a Great Choice for &#39;Trend&#39; Investors, Here&#39;s Why

General

ALPIB

BFCC

CFST

CMTV

EFSI

FDVA

FHBI

FRSB

IBTN

KISB

MCBI

RYFL

SBKK

VICTORY BANCORP INC by Victory Bancorp Inc.

VTYB

WRIV

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.


After Surviving 2020, The Future Looks Bright For Community Banks In 2021

PRIVATE BANCORP OF AMER by Private Bancorp of America, Inc.

Private Bancorp of America Inc

Barrington Research analyst Gary Prestopino maintains Stoneridge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SRI#NYSE">SRI</a>) with a Outperform and maintains $16 price target.

Barrington Research Maintains Outperform on Stoneridge, Maintains $16 Price Target

Morgan Stanley analyst Lee Simpson maintains Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) with a Overweight and lowers the price target from $625 to $590.

SNPS

Morgan Stanley Maintains Overweight on Synopsys, Lowers Price Target to $590

Barrington Research analyst Gary Prestopino maintains Koppers Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOP#NYSE">KOP</a>) with a Outperform and maintains $64 price target.

Barrington Research Maintains Outperform on Koppers Hldgs, Maintains $64 Price Target

Ascendiant Capital analyst Edward Woo maintains Outlook Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OTLK#NASDAQ">OTLK</a>) with a Buy and lowers the price target from $33 to $24.

OTLK

Ascendiant Capital Maintains Buy on Outlook Therapeutics, Lowers Price Target to $24

Barrington Research analyst Gary Prestopino maintains CCC Intelligent Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCCS#NASDAQ">CCCS</a>) with a Outperform and maintains $14 price target.

CCCS

Barrington Research Maintains Outperform on CCC Intelligent Solutions, Maintains $14 Price Target

Morgan Stanley analyst James Faucette maintains Nerdwallet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRDS#NASDAQ">NRDS</a>) with a Equal-Weight and lowers the price target from $15 to $12.

NRDS

Morgan Stanley Maintains Equal-Weight on Nerdwallet, Lowers Price Target to $12

Barrington Research analyst Gary Prestopino maintains Cars.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CARS#NYSE">CARS</a>) with a Outperform and maintains $25 price target.

CARS

Barrington Research Maintains Outperform on Cars.com, Maintains $25 Price Target

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) with a Buy and raises the price target from $4 to $4.25.

Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $4.25

Barrington Research analyst Alexander Paris maintains American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) with a Outperform and maintains $24 price target.

APEI

Barrington Research Maintains Outperform on American Public Education, Maintains $24 Price Target

EuroDry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EDRY#NASDAQ">EDRY</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.17) by 47.06 percent. This is a 135.71 percent decrease over earnings of $0.70 per share from the same period last year. The company reported quarterly sales of $14.51 million which missed the analyst consensus estimate of $15.01 million by 3.33 percent. This is a 8.76 percent decrease over sales of $15.90 million the same period last year.

Earnings Misses

EDRY

EuroDry Q4 Adj $(0.25) Misses $(0.17) Estimate, Sales $14.51M Miss $15.01M Estimate

BWMN

Bowman Consulting Group Has Been Awarded A One-year Contract By The State Of North Carolina's Center For Geographic Information And Analysis To Deliver High-resolution, 6-inch Pixel Digital Orthoimagery Covering The Counties Of Bladen, Johnston, Sampson, Wayne And Wilson In The State's Eastern Piedmont Region

RCAT

Red Cat Announced That Its Black Widow Drone And Flightwave Edge 130 Were Included On The List Of 23 Platforms And 14 Unique Components And Capabilities Selected As Winners Of The Blue UAS Refresh

D. Boral Capital analyst Jason Kolbert maintains OS Therapies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OSTX#AMEX">OSTX</a>) with a Buy and maintains $20 price target.

OSTX

D. Boral Capital Maintains Buy on OS Therapies, Maintains $20 Price Target

Morgan Stanley analyst Dara Mohsenian initiates coverage on Smithfield Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFD#NASDAQ">SFD</a>) with a Overweight rating and announces Price Target of $28.

Initiation

Morgan Stanley Initiates Coverage On Smithfield Foods with Overweight Rating, Announces Price Target of $28

Laboratory Corporation Of America Holdings

Labcorp Announced Today The Clinical Availability Of Labcorp Plasma Completetm, A Circulating Tumor Dna (Ctdna)-based Comprehensive Genomic Profiling Solution For Patients With Advanced Solid Tumors

Tech

JNPR

Juniper Networks Expands Routing Portfolio With the Launch Of  Juniper Networks ACX7020 Access Edge Router

D. Boral Capital analyst Jason Kolbert maintains Invivyd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IVVD#NASDAQ">IVVD</a>) with a Buy and maintains $9 price target.

IVVD

D. Boral Capital Maintains Buy on Invivyd, Maintains $9 Price Target

Morgan Stanley analyst Stephen Grambling downgrades Boyd Gaming (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYD#NYSE">BYD</a>) from Overweight to Equal-Weight and lowers the price target from $82 to $81.

Downgrades

Morgan Stanley Downgrades Boyd Gaming to Equal-Weight, Lowers Price Target to $81

Rosenblatt analyst Blair Abernethy maintains Altair Engineering (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTR#NASDAQ">ALTR</a>) with a Neutral and maintains $113 price target.

ALTR

Rosenblatt Maintains Neutral on Altair Engineering, Maintains $113 Price Target

Morgan Stanley analyst Meta Marshall upgrades Twilio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) from Equal-Weight to Overweight and raises the price target from $144 to $160.

Comments

Private Bancorp

Private Bancorp (PBAM) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga